52 Week Range
As of on the Shanghai Stock Exchange ∙ Minimum 15 minute delay
3M AVG Volume
52 Week High
52 Week Low
Shares Out (MIL)
Market Cap (MIL)
Dividend (Yield %)
Shanghai Pharmaceuticals <2607.Hk> Says 6-Month Net Profit Up 46.1% Y/Y
Shanghai Pharmaceuticals Got Acceptance Of Application For Proposed Non-Public Issuance Of A Shares From CSRC
BlackRock Inc Sold 2.8 Mln H-Shares In Shanghai Pharmaceuticals On May 31 - HKEX Filing
Shanghai Pharmaceuticals Holding Co Ltd is a China-based company principally engaged in pharmaceutical industry, distribution and retail business. The Company's products include innovative drugs, chemical drugs, traditional Chinese medicines and rare disease drugs. The Company's products are mainly used in the cardiovascular system, digestive tract and metabolism, systemic anti-infection, central nervous system, anti-tumor and immunomodulators, musculoskeletal system and respiratory system. In addition, the Company also provides medical logistics and warehousing services. The Company distributes its products both in the domestic market and to overseas markets.
Shanghai Pharmaceutical Mansion
No.200 Taicang Road
Chairman of the Board, Non-Executive Director
President, Executive Director
Vice Chairman of the Board, Non-Executive Director
Chief Financial Officer, Vice President, Executive Director
Vice President, Executive Director
Price To Earnings (TTM)
Price To Sales (TTM)
Price To Book (MRQ)
Price To Cash Flow (TTM)
Total Debt To Equity (MRQ)
LT Debt To Equity (MRQ)
Return on Investment (TTM)
Return on Equity (TTM)
An experimental coronavirus vaccine developed by West China Hospital has entered a mid-stage human test, authorities of China's southwestern province of Sichuan said on Tuesday.
Drugmakers have slashed prices by up to 95% to win state contracts in China's largest bidding round of its drug procurement programme, state media said on Thursday.
Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.